Replies to post #34735 on Revive Therapeutics Ltd (RVVTF)

[Ecomike]

Not if they thread the needle right. There could be unblindable data to see that could be used with extended follow up of test persons medical histories since the trial testing went on hold, that shows that Placebos got Long haul Covid and none of the Bucillamine dosed folks got long Covid. That would require the rest of the data, and test people follow up of their outcomes long term... and some elbow grease and horse trading with the FDA, or just get the all data and after trial case history, publish it, and sell out to Pfizer for 10 Billion dollars?

That may be part of what all the horse trading with the FDA is all about. It would be, if it was me...

[Ecomike]

That depends, and the question is not complete.

1) they could approval and EUA, and they test it on folks with long haul covid

2) They can open up the existing data, and then go out and collect the history in tested people to see if those that took Bucilamine, avoided Long haul covid versus placebos, before or after the FDA EUA approval is issued

3) They could modify the trial, and add Long haul covid people, if the FDA allows that sort of thing, but that gets complicated....

4) The could get the EUA approval for covid and then run clinical trials on Long Haul covid, with out a phase 3, if it is already approved for covid.

Lots and lots options....